| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. | Director | Common Stock | 5,010 | $18,236 | $3.64 | 09 Jun 2023 | Direct |
| Aardvark Therapeutics, Inc. | Director | Stock Option (right to buy) | 30,508 | 11 Jun 2025 | Direct | ||
| CG Oncology, Inc. | Director | Director Stock Option (right to buy) | 24,165 | 05 Jun 2025 | Direct | ||
| CG Oncology, Inc. | Director | Stock Option (Right to Buy) | 15,600 | 04 Oct 2024 | Direct | ||
| Finch Therapeutics Group, Inc. | Director | Stock Option (right to buy) | 10,000 | 08 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:05 |
| CGON | CG Oncology, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:01 |
| AARD | Aardvark Therapeutics, Inc. | 12 Feb 2025 | 0 | $0 | 3 | Director | 12 Feb 2025, 19:17 |
| CGON | CG Oncology, Inc. | 04 Oct 2024 | 1 | $0 | 4 | Director | 07 Oct 2024, 17:09 |
| CGON | CG Oncology, Inc. | 24 Jan 2024 | 0 | $0 | 3 | Director | 24 Jan 2024, 20:55 |
| FNCH | Finch Therapeutics Group, Inc. | 08 Jun 2023 | 2 | +$1,353 | 4 | Director | 09 Jun 2023, 16:15 |
| FNCH | Finch Therapeutics Group, Inc. | 13 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 17:04 |